Young David
Insider CIK 1378166 · PCSA President & CEO, Director, 10% owner · QCOR Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals, | P Buy | 2026-06-30 | 2026-07-01 | 2,531 | $1.93 | $4.9K | 21,729 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-06-15 | 2026-06-16 | 2,067 | $2.22 | $4.6K | 19,198 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-05-29 | 2026-06-01 | 1,786 | $2.57 | $4.6K | 17,131 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-05-15 | 2026-05-19 | 1,545 | $2.97 | $4.6K | 15,345 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-30 | 2026-05-01 | 1,706 | $2.69 | $4.6K | 13,813 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-15 | 2026-04-17 | 1,545 | $2.97 | $4.6K | 12,107 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-03-31 | 2026-04-01 | 1,810 | $2.54 | $4.6K | 10,562 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2026-01-01 | 2026-02-04 | 49 | — | $0 | 0 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2026-01-01 | 2026-02-04 | 49 | — | $0 | 8,752 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 333,000 | — | $0 | 333,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 111,000 | — | $0 | 111,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-07-24 | 2025-07-28 | 1,813,133 | — | $0 | 1,821,016 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2025-04-01 | 2025-04-11 | 17,272 | — | $0 | 222,677 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2025-04-01 | 2025-04-11 | 5,345 | $0.41 | $2.2K | 217,332 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-01-29 | 2025-02-18 | 62,250 | — | $0 | 62,250 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-01-29 | 2025-02-18 | 124,500 | — | $0 | 124,500 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2025-01-27 | 2025-01-29 | 124,500 | $0.80 | $99.6K | 205,405 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-07-10 | 2024-08-02 | 644 | — | $0 | 81,187 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-07-10 | 2024-08-02 | 282 | $1.71 | $482 | 80,905 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 2,425 | — | $0 | 24,347 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 3,233 | — | $0 | 21,922 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 404 | — | $0 | 24,751 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 404 | — | $0 | 25,155 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-04-05 | 2024-08-02 | 518 | $2.79 | $1.4K | 80,543 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-04-05 | 2024-08-02 | 1,675 | — | $0 | 81,061 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2024-02-07 | 2024-02-08 | 21,000 | $2.45 | $51.5K | 79,387 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2024-02-06 | 2024-02-07 | 20,000 | $2.53 | $50.6K | 58,387 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2024-01-01 | 2024-04-12 | 1,675 | — | $0 | 19,333 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-01-01 | 2024-04-12 | 1,675 | — | $0 | 81,062 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-01-01 | 2024-04-12 | 518 | $2.79 | $1.4K | 80,544 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-12 | 2023-10-12 | 155,277 | $0.29 | $45.0K | 767,701 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-10 | 2023-10-10 | 142,000 | $0.24 | $34.1K | 612,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2023-06-12 | 2023-06-12 | 40,000 | $0.80 | $32.0K | 470,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2023-04-14 | 2023-04-14 | 20,000 | $0.55 | $11.0K | 430,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2023-04-13 | 2023-04-13 | 20,000 | $0.48 | $9.6K | 410,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2023-04-12 | 2023-04-13 | 20,000 | $0.45 | $9.0K | 390,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2023-04-11 | 2023-04-13 | 20,000 | $0.52 | $10.4K | 370,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-02-09 | 2023-02-10 | 18,750 | $0.80 | $15.0K | 350,424 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-01-01 | 2023-01-04 | 24,030 | — | $0 | 424,373 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-12-31 | 2023-01-04 | 25,350 | — | $0 | 400,343 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-09-30 | 2022-10-03 | 25,350 | — | $0 | 374,993 | SEC↗ |
| PCSA Processa Pharmaceuticals, | G Gift | 2022-08-16 | 2022-08-23 | 9,250 | — | $0 | 377,784 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2022-08-05 | 2022-08-09 | 2,531 | $3.17 | $8.0K | 387,034 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2022-08-05 | 2022-08-09 | 7,601 | — | $0 | 389,565 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-06-30 | 2022-07-05 | 46,877 | — | $0 | 349,643 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-04-01 | 2022-04-11 | 247,841 | — | $0 | 302,766 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-03-31 | 2022-04-04 | 10,715 | — | $0 | 37,781 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-12-31 | 2022-01-04 | 6,722 | — | $0 | 6,722 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-12-31 | 2022-01-06 | 6,722 | — | $0 | 22,780 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-11-01 | 2022-04-04 | 4,286 | — | $0 | 27,066 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-09-30 | 2022-01-06 | 6,024 | — | $0 | 16,058 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-09-30 | 2021-10-04 | 6,024 | — | $0 | 6,024 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2021-08-05 | 2021-08-09 | 7,601 | — | $0 | 381,964 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 1,907 | — | $0 | 10,034 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 8,572 | — | $0 | 8,572 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 12,858 | — | $0 | 12,858 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-06-23 | 2021-06-23 | 10,000 | $7.67 | $76.7K | 345,190 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-06-08 | 2021-06-10 | 8,127 | — | $0 | 8,127 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 71,000 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 22,500 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 1,500 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 74,375 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 85,416 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-08-14 | 2014-08-18 | 14,000 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-08-14 | 2014-08-18 | 32,750 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-08-14 | 2014-08-18 | 70,991 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-06-24 | 2014-06-26 | 6,000 | — | $0 | 71,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2014-06-24 | 2014-06-26 | 6,000 | $91.96 | $551.8K | 117,741 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-06-24 | 2014-06-26 | 6,000 | $4.54 | $27.2K | 117,741 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-03-14 | 2014-03-18 | 6,000 | — | $0 | 77,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-03-14 | 2014-03-18 | 6,000 | $4.54 | $27.2K | 117,741 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2014-03-14 | 2014-03-18 | 2,587 | $61.78 | $159.8K | 115,154 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2014-03-14 | 2014-03-18 | 3,413 | $62.65 | $213.8K | 111,741 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-03-03 | 2014-03-05 | 6,000 | — | $0 | 1,500 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-03-03 | 2014-03-05 | 6,000 | $5.77 | $34.6K | 111,741 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-02-24 | 2014-02-26 | 6,000 | — | $0 | 83,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-02-24 | 2014-02-26 | 16,667 | — | $0 | 122,478 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2014-02-24 | 2014-02-26 | 14,000 | — | $0 | 125,145 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2014-02-24 | 2014-02-26 | 14,000 | — | $0 | 139,145 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | F Tax w/h | 2014-02-24 | 2014-02-26 | 17,127 | $79.46 | $1.36M | 105,351 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-02-24 | 2014-02-26 | 6,000 | $4.54 | $27.2K | 111,351 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2014-02-24 | 2014-02-26 | 6,000 | $78.88 | $473.3K | 105,351 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-01-29 | 2014-01-31 | 10,000 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-01-29 | 2014-01-31 | 10,000 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-01-29 | 2014-01-31 | 10,000 | $9.31 | $93.1K | 111,145 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-01-29 | 2014-01-31 | 10,000 | $5.77 | $57.7K | 101,145 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2014-01-24 | 2014-01-28 | 6,000 | — | $0 | 89,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2014-01-24 | 2014-01-28 | 6,000 | $64.38 | $386.3K | 91,145 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2014-01-24 | 2014-01-28 | 6,000 | $4.54 | $27.2K | 97,145 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2013-11-19 | 2013-11-21 | 15,000 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2013-11-19 | 2013-11-21 | 15,000 | $5.77 | $86.5K | 89,603 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2013-11-13 | 2013-11-15 | 100,000 | — | $0 | 95,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2013-11-13 | 2013-11-15 | 100,000 | $62.40 | $6.24M | 74,603 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2013-11-13 | 2013-11-15 | 100,000 | $4.54 | $454.0K | 174,603 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | G Gift | 2013-03-07 | 2013-03-08 | 10,625 | — | $0 | 10,625 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | G Gift | 2013-03-07 | 2013-03-08 | 10,625 | — | $0 | 75,666 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-02-24 | 2013-04-12 | 25,000 | — | $0 | 60,821 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-02-24 | 2013-04-12 | 25,000 | — | $0 | 85,821 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-02-24 | 2013-04-12 | 21,325 | — | $0 | 35,821 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-02-24 | 2013-02-26 | 25,000 | — | $0 | 60,235 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-02-24 | 2013-02-26 | 21,332 | — | $0 | 35,235 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-02-24 | 2013-02-26 | 25,000 | — | $0 | 85,235 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-08-10 | 2012-08-14 | 625 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-08-10 | 2012-08-14 | 10,000 | — | $0 | 195,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-08-10 | 2012-08-14 | 10,000 | $4.54 | $45.4K | 13,903 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-08-10 | 2012-08-14 | 625 | $1.47 | $919 | 3,903 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-04-27 | 2012-05-01 | 70,000 | — | $0 | 205,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-04-27 | 2012-05-01 | 70,000 | $4.54 | $317.8K | 73,278 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2012-04-27 | 2012-05-01 | 70,000 | $42.81 | $3.00M | 3,278 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2012-02-15 | 2012-02-17 | 90,000 | — | $0 | 90,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2012-02-15 | 2012-02-17 | 20,000 | — | $0 | 20,000 | SEC↗ |